New drug could shield preemie lungs from deadly disease
Prevention
Recruiting now
This study tests an investigational drug called zelpultide alfa to see if it can prevent bronchopulmonary dysplasia (BPD), a serious chronic lung disease, in extremely premature babies (born between 22 and 27 weeks). About 366 high-risk infants will receive either the drug or a p…
Phase: PHASE2, PHASE3 • Sponsor: Airway Therapeutics, Inc. • Aim: Prevention
Last updated Jul 17, 2026 00:00 UTC